Korea’s top biopharmaceutical firms, Celltrion and Samsung Biologics, envisioned their future strategies for expansion at J.P ...

SK Biopharmaceuticals and Eurofarma formed a joint venture to develop an AI platform for managing epilepsy. The focus ...

SK Biopharmaceuticals Co. (SK Biopharm), a biopharmaceutical arm of SK Group, will establish a joint venture with a major ...

SK Biopharmaceuticals plans to establish a joint venture with Eurofarma, one of Latin America’s leading pharmaceutical ...

Common measurements for modified adeno-associated viruses (AAVs), a gene therapy delivery method, showed substantial ...

CO. Ltd, today announced the first patient dosing in Australia on Dec 30, 2024 for Phase 1 clinical trial of HX044 in patients with advanced solid tumors.

Ltd, today announced the first patient dosing in Australia on Dec 30, 2024 for Phase 1 clinical trial of HX044 in patients with advanced solid tumors.

As we close out 2024, global markets have exhibited mixed signals with moderate gains in major stock indexes despite declining consumer confidence and manufacturing data. Amid these fluctuations, ...

We've identified the following companies as similar to Sk Biopharmaceuticals Co Ltd because they operate in a related industry or sector. We also considered size, growth, and various financial metrics ...

SK Life Science (SK Life), is a subsidiary of SK Biopharmaceuticals Co Ltd is a developer of next-generation drugs. The company’s pipeline products include SK-PSY which treats bipolar disorder; ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...